Myosin-binding protein C1 (MYBPC1) is an abundant skeletal muscle protein that is expressed predominantly in slow-twitch muscle fibers. Human MYBPC1 mutations are associated with distal arthrogryposis type 1 and lethal congenital contracture syndrome type 4. As MYBPC1 function is incompletely understood, the mechanism by which human mutations result in contractures is unknown. Here, we demonstrate using antisense morpholino knockdown, that mybpc1 is required for embryonic motor activity and survival in a zebrafish model of arthrogryposis. Mybpc1 morphant embryos have severe body curvature, cardiac edema, impaired motor excitation and are delayed in hatching. Myofibril organization is selectively impaired in slow skeletal muscle and sarcomere numbers are greatly reduced in mybpc1 knockdown embryos, although electron microscopy reveals normal sarcomere structure. To evaluate the effects of human distal arthrogryposis mutations, mybpc1 mRNAs containing the corresponding human W236R and Y856H MYBPC1 mutations were injected into embryos. Dominantnegative effects of these mutations were suggested by the resultant mild bent body curvature, decreased motor activity, as well as impaired overall survival compared with overexpression of wild-type RNA. These results demonstrate a critical role for mybpc1 in slow skeletal muscle development and establish zebrafish as a tractable model of human distal arthrogryposis.
INTRODUCTION
Distal arthrogryposis syndromes are a group of autosomal dominant disorders characterized by non-progressive congenital contractures of the distal limbs (1) . Ten different distal arthrogryposis syndromes have been described to date, including distal arthrogryposis type 1 that affects at least one in 10 000 individuals (2) . Patients with distal arthrogryposis type 1 have contractures that are limited to the hands and feet (1) . The majority of the genes implicated in distal arthrogryposis pathogenesis thus far encode components of the sarcomere or contractile apparatus of myofibers, including b-tropomyosin (TPM2), troponin I type 2 (TNNI2), troponin T type 3 (TNNT3), myosin heavy chain 3 (MYH3) (3) (4) (5) (6) and myosin-binding protein C1 (MYBPC1) (7) . Mutations in these genes are found in 40% of all distal arthrogryposis patients (8) . Despite the frequency with which these sarcomeric gene mutations are identified in distal arthrogryposis, remarkably few studies have addressed the mechanism by which these mutations cause limb contractures.
Genes encoding myosin-binding protein C belong to the intracellular immunoglobulin superfamily and are abundantly expressed in muscle (9) . Three genes encode myosin-binding protein C proteins in both human and mouse genomes and are expressed predominantly in slow skeletal muscle (MYBPC1), fast skeletal muscle (MYBPC2) and cardiac muscle (MYBPC3) (10, 11) . Cardiac MYBPC3 mutations were first described in 1995 and are now considered one of the most common causes of human hypertrophic cardiomyopathy (12, 13) . More recently, mutations in the slow skeletal muscle MYBPC1 gene were identified in two families with autosomal dominant distal arthrogryposis type 1 whose phenotype includes severe congenital clubfoot, vertical talus and camptodactyly (7) . The human MYBPC1 W236R and Y856H mutations are located within the myosin-binding protein C unique motif (M-motif) and the C-terminal C8 domain, respectively (7) . Exogenous expression of MYBPC1 containing these mutations in murine muscle demonstrated correct sarcomeric localization of MYBPC1 mutant proteins (7) , though the functional effects of these mutations were not evaluated. A recent report also described homozygous MYBPC1 nonsense mutations in two unrelated Bedoin families with autosomal recessive lethal congenital contracture syndrome type 4 (14) .
The myosin-binding protein C family of proteins plays important structural and regulatory roles in muscle function (reviewed 15). They provide thick filament stability by interacting with titin and the rod portion of sarcomeric myosin (light meromyosin) through its C-terminal region (16, 17) . The myosinbinding protein C unique M-motif modulates contractility through dynamic interactions with the head region (S2) of myosin and actin (18) (19) (20) . Critical residues within the M-motif also are phosphorylated by PKA and PKC (21) , presenting an additional mechanism by which myosin-binding protein C may regulate contractility (22, 23) . In addition to these structural functions, myosin-binding protein C1 also interacts with muscle-type creatine kinase, potentially allowing it to regulate energy homeostasis during muscle contraction by coupling to the myofibril (22) .
Although MYBPC3 mutations have been extensively studied for their role in human hypertrophic cardiomyopathy (reviewed in 24, 25) , research into MYBPC1 mutations is limited. Several lines of evidence suggest that the mechanism by which mutations in MYBPC1 and MYBPC3 cause disease may be very different. First, MYBPC3 mutations consist predominantly of nonsense mutations that are predicted to cause autosomal dominant hypertrophic cardiomyopathy through haploinsufficiency (25) (26) (27) , and even MYBPC3 missense mutations are associated with reduced MYBPC3 protein levels (26) . In contrast, although only two mutations in MYBPC1 have been described in distal arthrogryposis type 1, both are autosomal dominantly inherited missense mutations (7) . While MYPBC1 nonsense mutations have been described in autosomal recessive lethal congenital contracture syndrome 4 (LCCS4), there is no evidence for muscle disease in heterozygote carriers (14) . Secondly, in vivo experiments demonstrate that single amino acid substitutions in MYBPC3 cause the protein to fail to incorporate into the sarcomere, whereas single amino acid substitutions in MYBPC1 localize properly (7) . Despite their correct localization, however, the mechanisms by which MYBPC1 mutations cause the limb contractures characteristic of distal arthrogryposis are unknown. Genetic studies or knockouts have not been conducted in any animal model nor have there been prior functional studies of distal arthrogryposis sarcomeric gene mutations or reports of any genetically based animal models of distal arthrogryposis, all of which are needed to improve our understanding of this disorder.
In this study, we demonstrate that mybpc1 is required both for the development and function of slow skeletal muscle in zebrafish. Antisense morpholino oligonucleotide (MO)-mediated depletion of Mybpc1 expression results in severe ventral body curvature, decreased motility and early lethality, along with impaired sarcomere development with greatly reduced myofibril numbers. Furthermore, we also demonstrate that human MYBPC1 mutations exert dominant-negative effects on muscle function when expressed during zebrafish development, resulting in an embryo with a mild curvature that has impaired mobility. Because many mutations responsible for distal arthrogryposis are predicted to cause disease by a dominant-negative mechanism, the functional motor activity assay that we used to evaluate MYBPC1 gene mutations may be relevant to a variety of additional human disease genes.
RESULTS
Localization of mybpc1 to slow-twitch skeletal muscle sarcomere
The zebrafish genome contains a single mybpc1 ortholog on chromosome 4 that has 68.9% nucleotide identity with human MYBPC1. Mybpc1 transcripts are first detected as early as 9 h postfertilization (hpf), are present during somite development and myogenic differentiation between 12 and 24 hpf and become more abundant between 24 and 72 hpf (Fig. 1A) . Wholemount immunofluorescence using an anti-Mybpc1 antibody demonstrated sarcomeric localization in zebrafish embryo skeletal muscles (Fig. 1B) . Within the skeletal muscle, mybpc1 was uniquely expressed in the superficial slow-twitch axial muscles in all embryonic stages analyzed, consistent with previously published in situ data (28) . Expression overlaps entirely with slow-twitch myosin detected with the F59 antibody (29) . Mybpc1 protein localized to the C-zone of skeletal muscle fibers and was observed in its characteristic doublet pattern (Fig. 1C) .
Mybpc1 knockdown results in severe ventral body curvature
To determine if mybpc1 is required for normal zebrafish development, we employed antisense MOs to achieve knockdown of the mybpc1 gene function. Splice-site and translation start site blocking MOs were injected into 1-to 4-cell-stage embryos. The effectiveness of the mybpc1 MO to downregulate Mybpc1 protein expression was verified by western blotting. Mybpc1 morpholino reduced Mybpc1 protein expression level in embryos at both 1 and 2 days postfertilization (dpf) (Fig. 2A) .
Embryos injected with 1 ng of either mybpc1 MO exhibited mild ventral body curvature at 2 dpf (data not shown), and injection of 2 ng MOs resulted in a similar but more severe ventral body curvature (n ¼ 280; Fig. 2B ). Because both MOs resulted in identical phenotypes, all of the subsequent experiments were done using the splice-site MO. To confirm that the phenotype observed in mybpc1 morphants was a consequence of mybpc1 deficiency, we rescued mybpc1 morphants by coinjection of zebrafish mybpc1 mRNA that would not be sensitive to the splice-site MO. Embryos injected with mybpc1 mRNA alone revealed no phenotypic changes compared with control embryos (data not shown). Co-injection of mybpc1 MO and zebrafish mybpc1 mRNA resulted in the rescue of ventrally curved phenotype in 30% of embryos (50 out of 168 injected embryos) (Fig. 2B) . Morphant embryos also exhibited pericardial edema and poor growth of eyes and head (Fig. 2C) . Some mybpc1 morphants displayed massive cardiac edema that was associated with reduced heart rate, particularly after 3 dpf. These phenotypes were not observed in any embryos injected with a control antisense MO.
We also investigated whether the presence of a chorion influences the ventrally curved phenotype in mybpc1 morphants.
To examine this, embryos were dechorionated at 8 hpf, or 75% epiboly, so that growth could occur without the potential constraint of a chorion. A relatively straight body axis is present in dechorionated control MO-injected embryos at 1 dpf, whereas the mybpc1 morphants show ventral body curvature at 1 dpf regardless of the presence or absence of a chorion and the curvature remains throughout development (Fig. 2D) . Thus, the ventral body curvature in mybpc1 morphants is independent of the intact chorion.
Defective motor activity in mybpc1 morphants
We next examined the effects of mybpc1 knockdown on motor activity during zebrafish development. Embryos use muscular movements (e.g. a flip of the tail) to release themselves from their outer chorion. Although approximately 95% of control MO-injected embryos hatched from their chorion by 72 hpf, as expected from wild-type (WT) embryos (30) , only 50% of mybpc1-MO-injected embryos were hatched at this stage consistent with a decrease in overall muscle activity (Fig. 3A) .
Mybpc1 morphants also exhibited a decreased survival rate compared with control embryos. Although .90% (72/80) of control MO-injected embryos survived at 5 dpf, only ,5% (6/174) of mybpc1 morphant embryos survived at 5 dpf, and none lived to 7 dpf, indicating that mybpc1 knockdown is embryonic lethal (Fig. 3B) .
In zebrafish, the first recognizable skeletal muscle activity is spontaneous embryo coiling and flipping that appears between 20 and 28 hpf (31) and is due to slow-twitch muscle activity (32) . The frequency of spontaneous body coiling was reduced in mybpc1 MO compared with control MO-injected embryos at 24 hpf (8.32 + 0.33 versus 2.11 + 0.41, n ¼ 30, P , 0.0001). Furthermore, body coiling was weak in mybpc1 MO, with barely perceptible movements compared with the robust tail movements seen in control MO-injected embryos.
To quantify differences in this early motor activity, we measured the photomotor response, a stereotypic series of motor behaviors in response to a high-intensity light stimulus (33) . Presentation of a light stimulus induces a brief and strong motor excitation of embryos that resolves within 5 s after the stimulus. Basal activity was also measured for 3 s before the light stimulus. Using these testing parameters, both basal motor activity and photomotor responses were reduced in mybpc1 MO compared with control MO-injected embryos ( Fig. 3C and Supplementary Material, Videos S1 and S2). These data suggest that slow-twitch muscle function is severely affected by the reduction of Mybpc1.
The zebrafish escape response to tactile stimulation is a motor activity that appears later in development, around 72 hpf. Control MO-injected embryos respond to tactile stimulus with a rapid escape contraction. In contrast, knockdown of mybpc1 in zebrafish embryos resulted in loss of touch sensitivity with no evidence of skeletal muscle contraction in response to physical stimulation (Fig. 3D ).
Slow skeletal muscle myofibrils are disorganized in mybpc1 morphant embryos Because mybpc1 morphant movement was so severely impaired, we next examined the skeletal muscle for evidence of corresponding structural abnormalities. At a gross level, specification of slow and fast muscles appeared unaffected by mybpc1 knockdown when assessed with antibodies directed toward slow-(F59) or fast-twitch (F310) muscle myosin heavy chains (Supplementary Material, Fig. S1 ). However, the slow skeletal myofibers located most superficial in the embryo trunk were grossly disarrayed and the size and number of myofibrils were greatly reduced in mybpc1 morphant embryos (Fig. 4A ). This was in stark contrast to the well-organized slow skeletal muscles myofibers of control embryos. Central nuclei were present in morphant embryo slow muscle. Electron microscopy also demonstrated disorganized myofibrils in the mybpc1 morphant embryos, though individual sarcomere ultrastructure appeared relatively normal with regularly aligned A-bands, I-bands, Z-lines and M-lines ( Fig. 4B and Supplementary Material, Fig. S2 ). This provides evidence that mybpc1 is required for the normal development of slow skeletal muscle myofibers, but not the sarcomeres themselves.
To define the components of the skeletal muscle myofibril that are affected by mybpc1 knockdown, whole-mount immunofluorescence assays were performed to examine specific components of the sarcomere. Immunostaining with F59 revealed severely disrupted sarcomere formation and thick filament organization of slow muscles in mybpc1 morphant embryos in comparison to controls ( Fig. 4C and D) . Very few sarcomeres were detected in slow myofibers of mybpc1 knockdown embryos. In contrast, the organization of fast muscle sarcomeres was not altered in mybpc1 morphants as shown by staining with fast muscle myosin-specific antibody F310 in embryos at 1 dpf ( Fig. 4E and F) . To determine if mybpc1 loss affected the organization of thin filaments in slow muscle, immunostaining was performed using an anti-a-actin antibody. In the mybpc1 deficient state, thin filaments stained with the anti-a-actin antibody showed poor organization with little staining of sarcomeric structures in mybpc1-MO embryos compared with control MOinjected embryos ( Fig. 4G and H) .
To further understand the role of mybpc1 in the organization of other basic sarcomeric structures, we analyzed the localization of the Z-and M-line-specific proteins a-actinin and myomesin, respectively. Similar to a-actin staining, the sarcomeric localizations of both a-actinin in Z-line and myomesin in M-line were present, but markedly reduced, in mybpc1 morphants (Fig. 4I -L) .
Morphological examinations of heart in mybpc1 morphant embryo
Although Mybpc1 is primarily found in slow-twitch skeletal muscle, it is also expressed in human, rabbit, rat and bovine hearts (34) . Mybpc1 protein is also present in zebrafish heart at 2 dpf as detected with anti-mybpc1-specific antibody (Supplementary Material, Fig. 3A ). The phenotype of mybpc1 morphants included grossly apparent cardiac edema, low heart rate and cardiac enlargement with a misfolded, elongated morphology (Supplementary Material, Fig. 3B ). However, sarcomeres appeared well formed in the mybpc1 morphant heart as demonstrated by whole-mount immunostaining using the F59 myosin heavy chain antibody, suggesting that mybpc1 is not required for thick filament assembly in the heart.
Dominant-negative effects of Mybpc1 mutant protein expression
Because we previously showed that MYBPC1 mutant proteins incorporate correctly into sarcomeres (7), we hypothesized that these human mutations may cause disease through gain-of-function effects on muscle function. Multiple alignments revealed that human DA1 MYBPC1 mutations W236R and Y856H are highly conserved, and therefore, the corresponding W220R and Y845H mutations were introduced into the zebrafish mybpc1 sequence (Fig. 5A) . As a negative control, we also introduced into zebrafish mybpc1 sequence a mutation (H494Q), which corresponds to MYBPC1 H506Q human polymorphism (rs3817552) that is present at an overall minor allele frequency of 0.176. Because of its high frequency in humans, the H494Q mutation in zebrafish Mybpc1 is likely to be benign.
Mutant mRNAs with the corresponding distal arthrogryposis mutations were injected into zebrafish embryos in order to determine the presence of dominant-negative or gain-of-function effects on muscle activity. Overexpression of WT-mybpc1 mRNA did not result in any phenotype compared with uninjected control embryos. However, a bent body phenotype was observed at 4 dpf in some embryos injected with either W220R (31%, n ¼ 40/129) or Y845H (26%, n ¼ 33/124) mRNAs that was rarely observed in control, WT mybpc1 or embryos injected with the H494Q mRNA corresponding to the human common polymorphism ( Fig. 5B and C) .
To determine whether the bent body phenotypes in mutant embryos were associated with abnormal skeletal muscle myofiber organization, we performed thick filament immunostaining for muscle myosin heavy chains. Embryos injected with either W220R or Y845H-mybpc1 mRNA showed slow muscle fibers that were undulated and less tightly compacted compared with control uninjected or WT-mybpc1 mRNA-injected embryos (Fig. 5D) . At the ultrastructural level, the components of the sarcomere appeared unchanged compared with muscle of control uninjected or WT-mybpc1 RNA-injected embryos (Fig. 5E ). Myofibers were organized and normal in quantity. In contrast to the structural changes seen in slow-twitch muscle, fast skeletal muscle appeared morphologically normal in embryos expressing mutant protein when assessed with myosin heavy chain antibody at 4 dpf (Supplementary Material, Fig. S4 ).
Overexpression of both human distal arthrogryposis mutant mybpc1 mRNAs negatively affected embryonic motor activity throughout embryonic development. Spontaneous body coiling frequency at 24 hpf was reduced in W220R (6.45 + 0.61, n ¼ 60, P , 0.01) and Y845H-mybpc1 (6.90 + 0.75, n ¼ 60, P , 0.01) RNA-injected embryos compared with control uninjected embryos (8.95 + 0.61, n ¼ 60). Likewise, hatching was delayed in the embryos injected with either the W220R (16%; 11/65) or Y845H-mybpc1 (16%; 10/62) RNA compared with control uninjected embryos (50%; 44/88) at 2 dpf, although nearly all embryos were hatched by 3 dpf.
When this slow muscle activity was quantified using the photomotor response at 30 hpf, embryos injected with either the W220R or Y845H-mybpc1 RNA demonstrated statistically significant reduction in motor excitation compared with control uninjected and WT-mybpc1 RNA-injected embryos ( Fig. 5F and Supplementary Material, Fig. S5 ). However, the reduced motor response in the mybpc1 mutant RNA-injected embryos was not as dramatic as that observed in mybpc1-MO-injected embryos. As expected, overexpression of H494Q-mybpc1 variant corresponding to the common human MYBPC1 gene polymorphism did not have any effect on zebrafish motor activity. Touch-escape response was also impaired in the mutant RNA-injected embryos compared with the WT-mybpc1 RNA-injected embryo when assessed at 3 dpf. Although all control uninjected or WT-mybpc1 RNA-injected embryos responded normally by rapidly swimming out of the field, the W220R and Y845H mutants consistently moved only a few body lengths when touched (data not shown). Embryos injected with the mybpc1 mutant W220R or Y845H mRNA also failed to survive past 10 dpf, suggesting that the motor deficits were having significant effects on their overall survival (Fig. 5G) . While mild heart edema was seen in several of the mutant-injected embryos, none of the embryos were noted to have severe heart edema or reduced heart rates (data not shown).
DISCUSSION
Although myosin-binding protein C was discovered in skeletal muscle nearly 40 years ago, its function remains poorly understood (9). Our results demonstrate that the slow skeletal muscle mybpc1 gene is essential for normal zebrafish embryonic development. In fact, the mybpc1 morphant embryonic phenotype we describe here is remarkably similar to that recently described in fetuses with autosomal recessive lethal congenital contractural syndrome type 4 (LCCS4) due to homozygous nonsense mutations in MYBPC1 (14) .
We also demonstrate dominant-negative effects of human distal arthrogryposis MYBPC1 missense mutations on endogenous sarcomeric proteins. While the curved phenotype is not as penetrant or as severe as that seen in the mybpc1 morphants, embryos overexpressing the zebrafish mybpc1 W220R and Y845H mutations (corresponding to W236R and Y856H human MYBPC1 mutations) have severe motor deficits and as a consequence, decreased survival. As we previously observed normal sarcomeric localization of mutant human MYBPC1 mutations (W236R and Y856H) in vivo (7), distal arthrogryposis mutations exert their effects by altering sarcomere stability or by modifying skeletal muscle contractility through its interaction with other sarcomeric proteins. Myosin-binding protein C interacts directly with light meromyosin, actin, titin and the myosin head region (S2) (reviewed 15), thus providing multiple potential interactions that could be altered by the human mutations. In fact, Ackermann et al. recently reported that these same human distal arthrogryposis mutations alter the ability of recombinant MYBPC1 fragments to interact with myosin and actin in vitro, thereby abolishing its actomyosin regulatory properties (35) . Further studies directed at investigating each of these potential functions are needed to determine the mechanism by which distal arthrogryposis MYBPC1 mutations disrupt sarcomeric function.
In contrast to the dominant-negative effects of MYBPC1 mutations on muscle function, the vast majority of MYBPC3 mutations associated with human hypertrophic cardiomyopathy cause disease through gene haploinsufficiency (25, 36) . Although the allelic series of MYBPC1 mutations is still too small to make conclusions about the range and types of mutations causing distal arthrogryposis, MYBPC1 haploinsufficiency was not reported to cause muscle disease in the heterozygous parents or relatives of the fetuses with lethal congenital contractural syndrome due to homozygous MYBPC1 nonsense mutations (14) . Because MYBPC1 mutations appear to cause disease through a potentially different mechanism than MYBPC3 mutations, functional studies No curve is present in control uninjected zebrafish, or in zebrafish overexpressing WT mybpc1 or mybpc1 containing a common human polymorphism H494Q. (D) Abnormal slow muscle fiber organization in W220R and Y845H-mybpc1 mutant embryos showing wavy myofibers with increased distance between fibers as shown by whole-mount immunostaining with antibody to slow muscle myosin (F59) at 4 dpf. (E) Sarcomere ultrastructure is unchanged compared with control uninjected and WT-mybpc1 RNA overexpressing embryos when evaluated by electron microscopy. (F) Embryos overexpressing W220R and Y845H-mybpc1 show decreased motor excitation in response to light stimulus compared with control or WT-mybpc1 overexpressing embryos as measured by the mean motion index of three separate batches of injected embryos. Embryos overexpressing the H494Q-mybpc1 common human polymorphism have a similar photomotor response to control uninjected and WT-mybpc1 embryos ( * P , 0.05; * * P , 0.01). (G) Decreased survival of embryos overexpressing W220R and Y845H-mybpc1 assessed at 7 dpf ( * P , 0.01).
of both distal arthrogryposis and hypertrophic cardiomyopathy mutations are likely to provide complementary insights into the unique properties of both proteins. The presence of cardiac edema, reduced heart rate, and abnormal heart looping in our mybpc1 morphant fish also suggests that mybpc1 may be necessary for early heart development, although it is possible that these findings are non-specific and secondary to impaired mobility. Although early studies failed to find evidence for Mybpc1 expression in murine or human heart (37), Mybpc1 protein expression was more recently shown in normal adult mammalian heart (34) . Here, we demonstrate Mybpc1 protein expression during early zebrafish cardiac development. Interestingly, the lethal phenotype observed in our mybpc1 morphant fish lies in contrast to the lack of any apparent early developmental phenotype when cardiac mybpc3 expression was abolished in mice (38) . Thus, mybpc1 may be sufficient to support normal cardiac development in the absence of mybpc3 expression.
Human contractures in distal arthrogryposis are hypothesized to be due to reduced movement in utero. We demonstrate an association between impaired motor activity and curved body phenotypes in both the mybpc1 morphant zebrafish and embryos overexpressing mybpc1-distal arthrogryposis mutations. The mybpc1 morphants show predominantly a ventral body curvature, while many other zebrafish with deficits in motor activity are more dorsally curved, including the zebrafish neb embryos (39), slow muscle-specific a-actinin-2 morphant (40) and mtm1 morphants (41) . However, absent movement at 24 hpf does not by itself appear to be sufficient for the development of a curved phenotype. For example, zebrafish smyhc1 (slow skeletal muscle myosin heavy chain) morphants are paralyzed at 24 hpf yet have a normal straight body phenotype (42) . Furthermore, the significance of the ventral curved zebrafish phenotype is also complicated by its non-specific nature, as a similar curved shape has also been reported zebrafish models of muscular dystrophy (43) (44) (45) . Future studies are needed to determine whether alterations of other distal arthrogryposis-associated sarcomeric genes, including MYH3, TNNT3, TPM2 and TNNI2, result in similar embryonic curved phenotypes and whether the motor deficits are always concordant with a change in body axis.
Because some human contractures are associated with constrained fetal movement (46), we wondered whether the presence of an intact chorion contributed to the highly curved phenotype we observed in our mybpc1-morphant fish. Thus, by taking advantage of unique aspects of zebrafish development and removing the chorion, we showed that the contracted phenotype in the mybpc1 morphants was primarily the result of abnormal muscle development with no contribution made by the presence of an intact chorion.
In addition to providing a tool by which the basic mechanisms of contracture formation can be studied, the zebrafish model of distal arthrogryposis can also be used to quantify the deleterious effects of human MYBPC1 gene variants. By quantitatively measuring embryonic motor function in response to a light stimulus, we were able to distinguish between deleterious human disease causing mutations and a benign MYBPC1 polymorphism that has no effect on motor function. Since the mutant RNA is injected early during development, the mutant proteins are likely expressed in all muscle, including cardiac, fast and slow muscle; therefore, this approach likely does not yield a fully accurate human disease model. Yet, it remains useful for testing functional consequences of human mutations because of the robust motor phenotype. Because many distal arthrogryposis-associated genes are associated with extensive genetic variation even in controls without muscle disease (3), distinguishing normal variants from those that are pathogenic poses a major challenge. Since mutations in many other distal arthrogryposis-associated genes are also predicted to cause dominant-negative effects, the quantitative assay we describe here may be used to study the functional effects of variants that are currently classified as being of unknown significance in a variety of human disease genes.
This study addresses the need for tractable models of human arthrogryposis and demonstrates that zebrafish can effectively model the effects of MYBPC1 mutations associated with lethal congenital contracture syndrome and distal arthrogryposis. Our current findings provide evidence that dominant-negative and loss-of-function mutations in MYBPC1 result in distal arthrogryposis and lethal congenital contracture syndrome type 4, respectively, and establish a critical role for MYBPC1 in embryonic muscle development. As studies of arthrogryposis move from gene discovery to the translational development of novel treatment methods, zebrafish models are likely to become valuable tools for the identification of disease-modifying pharmaceuticals that may be useful new treatments for patients with these congenital contracture syndromes.
MATERIALS AND METHODS

Zebrafish and embryo maintenance
Wild-type zebrafish (Danio rerio) were maintained and embryos were raised as described (47) . The wild-type AB fish were obtained from Zebrafish International Resource Center. Fish were anesthetized for squeezing using tricaine methanesulfonate (3-amino benzoic acidethylester, Sigma) at a final concentration of 0.16% in E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2 , MgSO 4 in H 2 O). All animal work was approved by the animal studies committee of Washington University.
Microinjection of MOs and mRNA into embryos
All antisense MOs targeting zebrafish mybpc1 were purchased from Gene Tools, LLC (Philomath, OR, USA). The sequences for standard control and mybpc1 MOs targeting intron 3-exon 4 (splice-blocking) and ATG start codon (translation-blocking) were as follows: standard control, 5
′ -CCTCTTACCTCAG TTACAATTTATA-3 ′ ; splice-blocking MO, 5 ′ -TATCATCTG AACAGAGACAGAGAGA-3 ′ ; translation-blocking MO, 5 ′ -GC TCAGGCATGTTGAGCCGTTCTCC-3 ′ . The 3 ′ end of standard control and splice-blocking MOs were modified with Lissamine tag. MOs were dissolved in nuclease-free water, and 1 nl (2 ng) was injected into 1-to 4-cell-stage embryos.
For the overexpression of either wild-type or mutant zebrafish mybpc1, the coding region of zebrafish mybpc1 mRNA was cloned into the pCS2+ multiple expression vector. W220R, Y845H and H494Q mutant zebrafish mybpc1 constructs were generated using QuickChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's protocol. mRNAs were synthesized using the mMESSAGE mMACHINE system (Ambion) and injected into embryos at 1 -4 cell stages.
Reverse transcription -polymerase chain reaction
To measure the mRNA expression of mybpc1, RNA was prepared from zebrafish embryos using RNeasy Mini Kit (Qiagen). RNA was reverse transcribed and converted into complementary DNA (cDNA) using the superscript II Reverse Transcription Kit (Invitrogen) according to the manufacturer's protocol. Reverse transcription-polymerase chain reaction (RT-PCR) was performed using the following primers: mybpc1, 5
′ -TTTGCC AAGAGATTGGAACC-3 ′ and 5 ′ -GATGTGCACTTTGGCA GAGA-3 ′ ; EF1a, 5 ′ -GATGCACCACGAGTCTCTGA-3 ′ and 5
′ -TGATGACCTGAGCGTTGAAG-3 ′ .
Immunofluorescence staining
For immunohistochemistry, embryos at either 1 or 2 dpf were dechorionated in protease type XIV (Sigma). Embryos were fixed with 4% paraformaldehyde (PFA) overnight at 48C, embedded in agarose and Tissue-Tek O.C.T. medium (Sakura Finetek USA). Then, the blocks containing the embryos were frozen in liquid nitrogen-chilled methyl butane and sectioned. The sections were permeabilized with 0.1% Triton X-100, 1% BSA, 1% DMSO in PBS for 10 min, blocked with blocking solution (2% normal goat serum in PBS) for 30 min and incubated with anti-MYBPC1 (abcam Cat# ab55559), anti-F59 (Developmental Studies Hybridoma Bank) (DSHB) or anti-F310 (DSHB) antibody in blocking solution overnight at 48C. After three washes with PBS, the sections were incubated with AlexaFluor488-conjugated secondary antibody for 2 h at RT. For whole-mount immunofluorescence, embryos were placed in 4% PFA for 1 h at RT, washed in 1% Triton X-100 in PBS, and permeabilized in ice cold acetone for 8 min. After incubation in blocking solution (10% FBS, 1% Triton X-100 in PBS) for 1 h at RT, embryos were immunostained with anti-Mybpc1 (abcam, ab55559), anti-F59 (DSHB) or anti-F310 (DSHB), anti-actin (American Research Products), anti-a-actinin (Sigma) or antimyomesin (DSHB) antibody in blocking solution overnight at 48C. Then, embryos were washed in 1% Triton X-100 in PBS three times and incubated with AlexaFluor488-conjugated secondary antibody overnight at 48C. Following staining, embryos were imaged using FV1000 confocal microscope (Olympus).
Measurement of spontaneous coiling rate and motion index
Spontaneous coiling rate was recorded as the number of events observed in 15 s for each embryo. Motion index of zebrafish embryos was measured as previously described with some modifications (33) . Embryonic behaviors were recorded at 30 frames/s using BB FlashBack Express Recorder software (Bluberry Software) under a dissecting microscope (Olympus  DP70) . To analyze the movement of each embryo, ImageJ software was used to convert each frame to black-and-white image. Then, the software tracked the light intensity for each embryo over 30 s. Motion index represents the mean of the absolute value of the difference in the light intensity for adjacent time points measured at 30 times/s for each embryo. All the experiments were performed in triplicate.
Touch-escape response assay
Mechanosensory stimuli were delivered to the 3 dpf embryos with insect pins. Embryonic behaviors were recorded using BB FlashBack Express Recorder software (Bluberry Software) under a dissection microscope (Olympus DP70). Time-lapse images of each embryonic behavior were exported using BB FlashBack Express Player software (Blueberry Software).
Western blotting
Embryos were dechorionated in deyolking buffer (55 mM NaCl, 1.8 mM KCl, 1.25 mM NaHCO 3 ) and homogenized in lysis buffer (20 mM Tris-HCl, pH 7.4, 1% Triton X-100, 150 mM NaCl) with complete protease inhibitor cocktail (Roche Applied Sciences). Total lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to nitrocellulose membrane. Membrane were blocked in 5% skim milk for 1 h and incubated with anti-Mybpc1 or anti-a-tubulin (DSHB) antibody overnight at 48C. Membranes were washed with 0.1% PBST (0.1% Tween 20 in PBS) and incubated with a secondary antibody conjugated to horseradish peroxidase for 2 h at RT. Blots were developed with a chemiluminescent substrate enhanced chemiluminescence (GE Healthcare).
Birefringence assay
Muscle birefringence was analyzed by placing anesthetized embryos on a glass polarizing filter and covering them with a second polarizing filter on an ZEISS AXIOSKOP microscope (Carl Zeiss). The top polarizing filter was twisted until the light refracting through the striated muscle was visible (48) .
Histology and electron microscopy
Anesthetized embryos were chemically fixed by immersion in 3% glutaraldehyde in 0.1 M cacodylate buffer for 3 h. After rinsing in the cacodylate buffer, they were fixed in 2% osmium tetroxide in the same buffer, rinsed in water, dehydrated in acetone series and embedded in Araldite (Ted Pella). For light microscopy, 0.5-0.7 mm thick sections were cut and stained with toluidene blue and imaged in Leica DM2500 microscope fitted with a camera running Leica Application Suite. For electron microsopy, thin sections, 100 nm thick, were cut with a Reichert Ultracut E ultramicrotome, picked on uncoated 700-mesh hexagonal grids and stained with uranyl acetate (1:1, 2% uranyl acetate:ethanol, 30 min) followed by Reynolds lead citrate (30 min). They were imaged with a Jeol 1200 EX electron microscopy fitted with a Tietz FastScan CCD camera running TVIPS software (Tietz). Great care was taken in distinguishing slow fibers from fast fibers. Slow fibers are superficial, whereas fast fibers are deeper. Slow fibers in fish run parallel to the axis of the fish while fast fibers run parallel to the myotomes, with the appearance of the barbed end of an arrow (49) .
Statistical analysis
Differences in coiling frequency, mean motion index, and survival were quantified with a one-way ANOVA. All error bars shown represent standard error of the mean.
